BEGIN:VCALENDAR VERSION:2.0 PRODID:-//ChamberMaster//Event Calendar 2.0//EN METHOD:PUBLISH X-PUBLISHED-TTL:P1H REFRESH-INTERVAL:P1H CALSCALE:GREGORIAN BEGIN:VTIMEZONE TZID:America/New_York BEGIN:DAYLIGHT RRULE:FREQ=YEARLY;BYMONTH=3;BYDAY=2SU DTSTART:20070101T000000 TZOFFSETFROM:-0500 TZOFFSETTO:-0400 TZNAME:Eastern Daylight Time END:DAYLIGHT BEGIN:STANDARD RRULE:FREQ=YEARLY;BYMONTH=11;BYDAY=1SU DTSTART:20070101T000000 TZOFFSETFROM:-0400 TZOFFSETTO:-0500 TZNAME:Eastern Standard Time END:STANDARD END:VTIMEZONE BEGIN:VEVENT DTSTART;TZID=America/New_York:20211104T130000 DTEND;TZID=America/New_York:20211104T140000 X-MICROSOFT-CDO-ALLDAYEVENT:FALSE SUMMARY:Infection Prevention for Medical Products: What You Need to Know DESCRIPTION:Growing trends involving drug-resistant microbes and hospital-acquired infections that can result in complications\, morbidity\, and death are concerning healthcare providers. Infection prevention is critical for manufacturers and users of medical devices\, as these products can harbor drug-resistant microbes and transmit device-related infections even after the devices have been disinfected. FDA has responded to increased infection rates with guidance and numerous recommendations for industry as the agency intensifies its scrutiny of product design and use. Our panel of experts will address: Causes of medical device infections Design strategies for infection prevention for single-use and reusable devices Intellectual property (IP) and product liability matters Environmental concerns FDA regulatory implications such as design verification and validation (V&V) Register now X-ALT-DESC;FMTTYPE=text/html:
Growing trends involving drug-resistant microbes and hospital-acquired infections that can result in complications\, morbidity\, and death are concerning healthcare providers. Infection prevention is critical for manufacturers and users of medical devices\, as these products can harbor drug-resistant microbes and transmit device-related infections even after the devices have been disinfected. FDA has responded to increased infection rates with guidance and numerous recommendations for industry as the agency intensifies its scrutiny of product design and use. \;
Our panel of experts will address: \;